Innovative Cellular Therapeutics Holdings, Ltd.

Innovative Cellular Therapeutics, Inc.

Yuzhe Peng

Zhiyuan Cao

Lei Xiao

Zhao Wu

Wei Ding

Wensheng Wang

Le Tian

The compositions and methods described herein are directed to treating solid tumors using CAR T therapy and/or antibodies targeting GCC. The compositions include CAR comprising an extracellular domain that binds GCC.

Nanobody target GCC and uses in chimeric antigen receptor cell therapy

The present disclosure describes compositions and methods for treating cancer. Embodiments relate to a cell modified to express one or more molecules at a level that is higher or lower than the level of the one or more molecules expressed by a cell that has not been modified to express the one or more molecules, wherein the one or more molecules comprise Cavin3, ZBED2, and MYC.

Modified cell and use thereof in gene and cell therapy

Growing community of inventors

Shanghai, China

Yuzhe Peng